Skip to main content

Articles

Page 12 of 12

  1. Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct, indirect and intangible dimensions. They are intended to provide estimates about the economic...

    Authors: Nagede Costa, Helene Derumeaux, Thomas Rapp, Valérie Garnault, Laura Ferlicoq, Sophie Gillette, Sandrine Andrieu, Bruno Vellas, Michel Lamure, Alain Grand and Laurent Molinier
    Citation: Health Economics Review 2012 2:18
  2. It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventi...

    Authors: Kevin Marsh, Ceri J Phillips, Richard Fordham, Evelina Bertranou and Janine Hale
    Citation: Health Economics Review 2012 2:17
  3. The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative ...

    Authors: Francesc Homar, Virginia Lozano, Juan Martínez-Gómez, Itziar Oyagüez, Antonio Pareja, Antoni Payeras, Joaquín Serrano, Carmen Carratalá and Miguel Ángel Casado
    Citation: Health Economics Review 2012 2:16
  4. Prepayments and risk pooling through social health insurance has been advocated by international development organizations. Social health insurance is seen as a mechanism that helps mobilize resources for heal...

    Authors: Philip Ayizem Dalinjong and Alexander Suuk Laar
    Citation: Health Economics Review 2012 2:13
  5. Osteoporotic fractures impose a huge economic burden on society. Though several cost of illness studies from other countries exist, no equivalent study has been conducted in Austria. Our study aims at assessin...

    Authors: Hans Peter Dimai, Kurt Redlich, Monika Peretz, Fredrik Borgström, Uwe Siebert and Jörg Mahlich
    Citation: Health Economics Review 2012 2:12
  6. An understanding of the complex relationship between health status and welfare is crucial for critical policy interventions. However, the focus of most policies in developing regions has been on current welfar...

    Authors: Jacob Novignon, Justice Nonvignon, Richard Mussa and Levison S Chiwaula
    Citation: Health Economics Review 2012 2:11
  7. We propose simple modifications for the Kakwani tax progressivity measure that make it suitable for evaluating access inequality for medical services. Our modification is to measure inequality using the ratio ...

    Authors: Mototsugu Fukushige, Noriko Ishikawa and Satoko Maekawa
    Citation: Health Economics Review 2012 2:10
  8. The aim of the study was to determine the costs of treating schizophrenia from the perspective of the statutory health insurance, as well as the identification of predictors of hospitalisation of formerly stab...

    Authors: Jan Zeidler, Lara Slawik, Jochen Fleischmann and Wolfgang Greiner
    Citation: Health Economics Review 2012 2:9
  9. Physician ownership of in-office ancillary services (IOASs) has come under increasing scrutiny. Advocates of argue that IOASs allow physicians to supervise the quality and coordination of care. Critics have ar...

    Authors: John E Schneider, Robert L Ohsfeldt, Cara M Scheibling and Sarah A Jeffers
    Citation: Health Economics Review 2012 2:7
  10. Community-Based Health Insurance (CBHI) is an emerging concept for providing financial protection against the cost of illness and improving access to quality health services for low-income rural households who...

    Authors: Hermann Pierre Pythagore Donfouet and Pierre-Alexandre Mahieu
    Citation: Health Economics Review 2012 2:5
  11. Invasive (IPD, defined as detection of pneumococci in sterile body fluids like meningitis or bacteremic pneumonia) and non-invasive Streptococcus pneumoniae infections (i.e. non-bacteremic pneumonia, otitis media...

    Authors: Alexander Kuhlmann, Ulrike Theidel, Mathias W Pletz and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2012 2:4
  12. Opioid addiction is a worldwide problem. Agonist opioid treatment (AOT) is the most widespread and frequent pharmacotherapeutic approach. Methadone has been the most widely used AOT, but buprenorphine, a parti...

    Authors: Jose Martinez-Raga, Francisco Gonzalez-Saiz, Julian Oñate, Itziar Oyagüez, Eliazar Sabater and Miguel A Casado
    Citation: Health Economics Review 2012 2:3
  13. In April 2008, the specialization in departments of obstetrics and gynecology was conducted in Sennan area of Osaka prefecture in Japan, which aims at solving the problems of regional provision of obstetrical ...

    Authors: Junyi Shen, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Tadashi Kimura, Kenichiro Morishige and Tatsuyoshi Saijo
    Citation: Health Economics Review 2012 2:2
  14. Physician-induced demand (PID) is an important theory to test given the longstanding controversy surrounding it. Empirical health economists have been challenged to find natural experiments to test the theory ...

    Authors: Ke-Zong M Ma, Edward C Norton and Shoou-Yih D Lee
    Citation: Health Economics Review 2011 1:20
  15. As obesity and being overweight continue to increase in the United States, public concern is growing about the quality of American diets. We compare the changes in nutrients contributed by major food groups in...

    Authors: Kuo S Huang and Sophia Wu Huang
    Citation: Health Economics Review 2011 1:19
  16. This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the marke...

    Authors: Fritz von der Schulenburg, Sotiris Vandoros and Panos Kanavos
    Citation: Health Economics Review 2011 1:18
  17. This paper examines the effect of job stress on two key health risk-behaviors: smoking and alcohol consumption, using data from the Canadian National Population Health Survey. Findings in the extant literature...

    Authors: Sunday Azagba and Mesbah F Sharaf
    Citation: Health Economics Review 2011 1:15
  18. We study the effects of 'balance billing', i.e., allowing physicians to charge a fee from patients in addition to the fee paid by Medicare. First, we show that on pure efficiency grounds the optimal Medicare f...

    Authors: Mathias Kifmann and Florian Scheuer
    Citation: Health Economics Review 2011 1:14
  19. To our knowledge, the present study provides a first time assessment of the contributions of socioeconomic determinants of immunization coverage in India using the recent National Family Health Survey data. Me...

    Authors: Jørgen Lauridsen and Jalandhar Pradhan
    Citation: Health Economics Review 2011 1:11
  20. To compare improvement in quality of life (QoL) and symptoms' relief in vertebral compression fractures (VCF) due to osteoporosis for patients undergoing balloon kyphoplasty (BKP) to those undergoing non-surgi...

    Authors: Daniela Eidt-Koch and Wolfgang Greiner
    Citation: Health Economics Review 2011 1:7
  21. This study aims to identify the impact of a preterm birth on financial and emotional burden from the families' perspective. Additionally, a comprehensive schedule of recommendations for a sufficient evaluation...

    Authors: Jan-Marc Hodek, J-Matthias von der Schulenburg and Thomas Mittendorf
    Citation: Health Economics Review 2011 1:6
  22. There is comprehensive evidence of the positive health effects of physical activity, and transport authorities can enable this by developing infrastructure for cycling and walking. In particular, cycling to wo...

    Authors: Knut Veisten, Stefan Flügel, Farideh Ramjerdi and Harald Minken
    Citation: Health Economics Review 2011 1:3
  23. Because of an elevated serum phosphate level, patients who suffer from chronic kidney failure frequently tend to have cardiovascular calcification and are therefore exposed to a higher probability of a fatal e...

    Authors: Thomas Plagemann, Anne Prenzler and Thomas Mittendorf
    Citation: Health Economics Review 2011 1:1

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.7
    5-year Journal Impact Factor: 2.8
    Source Normalized Impact per Paper (SNIP): 1.218
    SCImago Journal Rank (SJR): 0.800

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 220

    Usage 2023
    Downloads: 566,888
    Altmetric mentions: 483